Yabao Pharmaceuticals and Salus Pharma Announce Strategic Partnership for Generic Drugs

BEIJING & MONMOUTH JUNCTION, N.J.–(BUSINESS WIRE)–#GenericDrugs–Yabao Pharmaceutical Co, Inc. (Shanghai Stock Exchange 600351) and Salus
Pharma LLC today announced a strategic partnership to co-develop,
manufacture and commercialize high technological barrier generic drugs
worldwide.

Under the terms of the agreement, Yabao will exclusively own rights to
commercialize certain Salus Pharma-developed products outside the U.S.
and to manufacture for worldwide markets, while Salus Pharma will retain
rights to commercialize in the U.S. Financial terms were not disclosed.

“Yabao is excited to collaborate with Salus Pharma, a specialty
pharmaceutical company engaged in the research and development of high
technological barrier controlled release formulation. This transaction
represents our first generic drug partnership with Salus within this
year,” commented Dr. Peng Wang, President of R&D and Head of
International Business, Yabao Pharmaceutical Co. “This partnership
further demonstrates that Yabao’s competitive R&D and manufacturing have
expanded into developed markets.”

About Yabao Pharmaceutical Co.

Yabao Pharmaceutical Co. (Shanghai Stock Exchange 600351) is a leading
China pharmaceutical company with fully integrated development,
manufacturing, and commercialization capabilities. Yabao recently has
been pursuing strategic development and commercialization partnerships
to bring high quality innovative or generic medicines into China. In
addition to strong clinical and regulatory capabilities, Yabao has
extensive expertise in formulation and API production and meets current
Good Manufacturing Practice (cGMP) requirements with two manufacturing
sites approved by U.S. FDA and a European agency, respectively. For more
information about Yabao Pharmaceutical Co., please visit www.yabao.com.cn.

About Salus Pharma LLC

Salus Pharma LLC (Monmouth Junction, New Jersey) is a privately held,
technology driven specialty pharmaceutical company engaged in drug
delivery technology development and generic & innovative product
development & manufacturing. Salus Pharma LLC utilizes its established
drug delivery technologies and know-how to develop innovative drug
products for new chemical entities, aging compounds near the end of
their life cycle, and difficult-to-formulate generics for highly
regulated pharmaceutical markets.

Contacts

Yabao Contact
Ms. Weina Liu, +86-10-5808-6285
liuweina@yabaoyaoye.com
or
Salus
Contact
Dr. Nuo (Nolan) Wang, +001-908-723-1209
nolan.wang@saluspharmallc.com